Literature DB >> 1988035

Endoproteolytic processing of the human protein C precursor by the yeast Kex2 endopeptidase coexpressed in mammalian cells.

D C Foster1, R D Holly, C A Sprecher, K M Walker, A A Kumar.   

Abstract

The human protein C precursor undergoes extensive co- and posttranslational modification during its biosynthesis in the liver. These modifications include glycosylation, gamma-carboxylation, and beta-hydroxylation of specific amino acids and endoproteolytic processing to remove the pre- and propeptides as well as the pair of basic amino acids which connect the light and heavy chains in the precursor. Previous studies with a recombinant mammalian expression system have indicated that the endopeptidase in several mammalian cell types which recognizes and cleaves this dibasic site has a substrate specificity for sites which also include a basic amino acid in the -4 position (Foster et al., 1990). Since the human protein C precursor has His154 in the -4 position, it is poorly and incompletely cleaved in BHK and several other mammalian cell lines and also apparently secreted from the liver as a mixed population of mature two-chain and precursor one-chain molecules. In the present study, a mammalian expression system has been used to study the effect of coexpressing the protein C precursor together with the yeast Kex2 endopeptidase which is known to recognize and process dibasic pairs within peptide precursors in yeast. Coexpression of the KEX2 gene resulted in complete conversion of the protein C precursor to the mature two-chain form. Amino-terminal sequencing of the cleavage products has indicated that the cleavage occurs in the correct location and that this site is preferentially recognized by the yeast endopeptidase within the context of the mammalian cell secretory pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988035     DOI: 10.1021/bi00216a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step.

Authors:  Kevin W Hallgren; Wen Qian; Anna V Yakubenko; Kurt W Runge; Kathleen L Berkner
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

2.  Processing and trafficking of clotting factor X in the secretory pathway. Effects of warfarin.

Authors:  C Stanton; R Wallin
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

3.  Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency.

Authors:  D Vidaud; J Emmerich; M Alhenc-Gelas; J Yvart; J N Fiessinger; M Aiach
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

4.  Thrombin activation of protein C requires prior processing by a liver proprotein convertase.

Authors:  Rachid Essalmani; Delia Susan-Resiga; Johann Guillemot; Woojin Kim; Vatsal Sachan; Zuhier Awan; Ann Chamberland; Marie-Claude Asselin; Kévin Ly; Roxane Desjardins; Robert Day; Annik Prat; Nabil G Seidah
Journal:  J Biol Chem       Date:  2017-05-03       Impact factor: 5.157

5.  Vitamin K-dependent carboxylation of the carboxylase.

Authors:  K L Berkner; B N Pudota
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

6.  Proteolytic maturation of protein C upon engineering the mouse mammary gland to express furin.

Authors:  R Drews; R K Paleyanda; T K Lee; R R Chang; A Rehemtulla; R J Kaufman; W N Drohan; H Luboń
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Endoproteolytic processing of recombinant proalbumin variants by the yeast Kex2 protease.

Authors:  E C Ledgerwood; P M George; R J Peach; S O Brennan
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.

Authors:  C A Sprecher; W Kisiel; S Mathewes; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Inefficient processing of human protein C in the mouse mammary gland.

Authors:  W N Drohan; D W Zhang; R K Paleyanda; R Chang; M Wroble; W Velander; H Lubon
Journal:  Transgenic Res       Date:  1994-11       Impact factor: 2.788

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.